Objective: DNA copy number alterations and difference expression are frequently observed in ovarian cancer. The purpose of this way was to pinpoint gene expression change that w as associated with alterations in DNA copy number and could therefore enlighten some potential oncogenes and stability genes with functional roles in cancers, and investigated the bioinformatics significance for those correlated genes . Method: We obtained the DNA copy number and mRNA expression data from the Cancer Genomic Atlas and identified the most statistically significant copy number alteration regions using the GISTIC. Then identified the significance genes between the tumor samples within the copy number alteration regions and analyzed the correlation using a binary matrix. The selected genes were subjected to bio informatics analysis using GSEA tool. Results: GISTIC analysis results showed there were 45 significance copy number amplification regions in the ovarian cancer, SAM and Fisher’s exact test found there have 40 genes can affect the expression level, which located in the amplification regions. That means we obtained 40 genes which have a correlation between copy number amplification and drastic up- and down-expression, which p-value < 0.05 (Fisher’s exact test) and an FDR < 0.05. GSEA enrichment analysis found these genes w ere overlapped with the several published studies which were focused on the gene study of tumorigenesis. Conclusion: The use of statistics and bioinformatics to analyze the microarray data can found an interaction network involved. The combination of the copy number data and expression has pro vided a short list of candidate genes that are consistent with tumor driving roles. These would offer new ideas for early diagnosis and treat target of ovarian cancer.
KeywordsOvarian CancerCopy Number VariationGene Differential ExpressionSAM MethodGISTIC Method
Jemal, A., Siegel, R., Ward, E., et al. (2006) Cancer Statistics, 2006. CA: A Cancer Journal for Clinicians, 56, 106-130. https://doi.org/10.3322/canjclin.56.2.106
Bankhead, C. (2004) For Ovarian Cancer, an Optimal Treatment Remains to Be Found. Journal of the National Cancer Institute, 96, 96-97. https://doi.org/10.1093/jnci/96.2.96
Ozols, R.F., Bookman, M.A., Connolly, D.C., et al. (2004) Focus on Epithelial Ovarian Cancer. Cancer Cell, 5, 19-24. https://doi.org/10.1016/S1535-6108(04)00002-9
Cannistra, S.A. (2004) Cancer of the Ovary. The New England Journal of Medicine, 351, 2519-2529. https://doi.org/10.1056/NEJMra041842
Rosen, D.G., Yang, G., Deavers, M.T., et al. (2006) Cyclin E Expression Is Correlatedwith Tumor Progression and Predicts a Poor Prognosis in Patients with Ovarian Carcinoma. Cancer, 106, 1925-1932. https://doi.org/10.1002/cncr.21767
Haber, D.A. and Settleman, J. (2007) Cancer: Drivers and Passengers. Nature, 446, 145-146. https://doi.org/10.1038/446145a
Farley, J., Smith, L.M., Darcy, K.M., et al. (2003) Cyclin E Expression Is a Significant Predictor of Survival in Advanced, Suboptimally Debulked Ovarian Epithelial Cancers: A Gynecologic Oncology Group Study. Cancer Research, 63, 1235-1241.
Fan, B., Dachrut, S., Coral, H., et al. (2012) Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer. PLoS ONE, 7, e29824. https://doi.org/10.1371/journal.pone.0029824
Gorringe, K.L., Jacobs, S., Thompson, E.R., et al. (2007) High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications. Clinical Cancer Research, 13, 4731-4739. https://doi.org/10.1158/1078-0432.CCR-07-0502
Park, J.T., Li, M., Nakayama, K., et al. (2007) Notch3 Gene Amplification in Ovarian Cancer. Cancer Research, 66, 6312-6318. https://doi.org/10.1158/0008-5472.CAN-05-3610
Nanjunda, M., Nakayama, Y., Cheng, K.W., et al. (2007) Amplification of MDS1/ EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer. Cancer Research, 67, 3074-3084. https://doi.org/10.1158/0008-5472.CAN-06-2366
Greenman, C., Stephens, P., Smith, R., et al. (2007) Patterns of Somatic Mutation in Human Cancer Genomes. Nature, 446, 153-158.
Nakayama, K., Nakayama, N., Jinawath, N., et al. (2007) Amplicon Profiles in Ovarian Serous Carcinomas. International Journal of Cancer, 120, 2613-2617. https://doi.org/10.1002/ijc.22609
Snijders, A.M., Nowee, M.E., Fridlyand, J., et al. (2003) Genome-Wide Array-Based Comparative Genomic Hybridization Reveals Genetic Homogeneity and Frequent Copy Number Increases Encompassing CCNE1 in Fallopian Tube Carcinoma. Oncogene, 22, 4281-4286. https://doi.org/10.1038/sj.onc.1206621
Hough, C.D., Sherman-Baust, C.A., Pizer, E.S., et al. (2000) Large-Scale Serial Analysis of Gene Expression Reveals Genes Differentially Expressed in Ovarian Cancer. Cancer Research, 60, 6281-6287.
Welsh, J.B., Zarrinkar, P.P., Sapinoso, L.M., et al. (2001) Analysis of Gene Expression Profiles in Normal and Neoplastic Ovarian Tissue Samples Identifies Candidate Molecular Markers of Epithelial Ovarian Cancer. Proceedings of the National Academy of Sciences of the United States of America, 98, 1176-1181. https://doi.org/10.1073/pnas.98.3.1176
Tonin, P.N., Hudson, T.J., Rodier, F., et al. (2001) Microarray Analysis of Gene Expression Mirrors the Biology of an Ovarian Cancer Model. Oncogene, 20, 6617-6626. https://doi.org/10.1038/sj.onc.1204804
Olshen, A.B., Venkatraman, E.S., Lucito, R., et al. (2004) Circular Binary Segmentation for the Analysis of Array-Based DNA Copy Number Data. Biostatistics, 5, 557-572. https://doi.org/10.1093/biostatistics/kxh008
Venkatraman, E.S. and Olshen, A.B. (2007) A Faster Circular Binary Segmentation Algorithm for the Analysis of Array CGH Data. Bioinformatics, 23, 657-663. https://doi.org/10.1093/bioinformatics/btl646
Beroukhim, R., Getz, G., Nghiemphu, L., et al. (2007) Assessing the Significance of Chromosomal Aberrations in Cancer: Methodology and Application to Glioma. Proceedings of the National Academy of Sciences of the United States of America, 104, 20007-20012. https://doi.org/10.1073/pnas.0710052104
Cheng, L., Wang, P., Yang, S., et al. (2012) Identification of Genes with a Correlation between Copy Number and Expression in Gastric Cancer. BMC Medical Genomics, 5, 14. https://doi.org/10.1186/1755-8794-5-14
Masica, D.L. and Karchin, R. (2011) Correlation of Somatic Mutation and Expression Identifies Genes Important in Human Glioblastoma Progression and Survival. Cancer Research, 71, 4550-4561. https://doi.org/10.1158/0008-5472.CAN-11-0180
R Development Core Team (2006) A Language and Environment for Statistical Computing. Vienna.
Pollack, J.R., Sorlie, T., Perou, C.N., et al. (2002) Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration in the Transcriptional Program of Human Breast Tumors. Proceedings of the National Academy of Sciences of the United States of America, 99, 12963-12968. https://doi.org/10.1073/pnas.162471999
Haverty, P.M., Hon, L.S., Kaminker, J.S., et al. (2009) High-Resolution Analysis of Copy Number Alterations and Associated Expression Changes in Ovarian Tumors. BMC Medical Genomics, 2, 21. https://doi.org/10.1186/1755-8794-2-21
Nakayama, N.M., Nakayama, K., Shamima, Y., et al. (2010) Gene Amplification CCNE1 Is Related to Poor Survival and Potential Therapeutic Target in Ovarian Cancer. Cancer, 116, 2621. https://doi.org/10.1002/cncr.24987
Shih, I.M., Nakayama, K., Wu, G., et al. (2011) Amplification of the ch19p13.2 NACC1 Locus in Ovarian High-Grade Serous Carcinoma. Modern Pathology, 24, 638-645. https://doi.org/10.1038/modpathol.2010.230
Chen, L., Xuan, J., Gu, J., et al. (2012) Integrative Network Analysis to Identify Aberrant Pathway Networks in Ovarian Cancer. Pacific Symposium on Biocomputing, Kohala Coast, 3-7 January 2012, 31-42. https://doi.org/10.1142/9789814366496_0004
Cope, L., Wu, R.C., Shih, I.M. and Wang, T.L. (2013) High Level of Chromosomal Aberration in Ovarian Cancer Genome Correlates with Poor Clinical Outcome. Gynecologic Oncology, 128, 500-505. https://doi.org/10.1016/j.ygyno.2012.11.031
Jazaeri, A.A., Ferriss, J.S., Bryant, J.L., et al. (2010) Evaluation of EVI1 and EVI1s (Δ324) as Potential Therapeutic Targets in Ovarian Cancer. Gynecologic Oncology, 118, 189-195. https://doi.org/10.1016/j.ygyno.2010.04.007
Dutta, P., Bui, T., Bauckman, K.A., et al. (2013) EVI1 Splice Variants Modulate Functional Responses in Ovarian Cancer Cells. Molecular Oncology, 7, 647-668. https://doi.org/10.1016/j.molonc.2013.02.008
Wrzeszczynski, K.O., Varadan, V., Byrnes, J., et al. (2011) Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer. PLoS ONE, 6, e28503. https://doi.org/10.1371/journal.pone.0028503
Etemadmoghadam, D., DeFazio, A., Beroukhim, R., et al. (2009) Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas. Clinical Cancer Research, 15, 1417-1427.
Cancer Genome Atlas Research Network (2011) Integrated Genomic Analyses of Ovarian Carcinoma. Nature, 474, 609-615. https://doi.org/10.1038/nature10166